Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04729751
PHASE2

A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).

Sponsor: Mirum Pharmaceuticals, Inc.

View on ClinicalTrials.gov

Summary

This study is designed to assess whether the investigational drug maralixibat, is safe and well tolerated in children \<12 months of age with Alagille Syndrome \[ALGS\] or Progressive Familial Intrahepatic Cholestasis \[PFIC\].

Official title: Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille Syndrome

Key Details

Gender

All

Age Range

0 Days - 364 Days

Study Type

INTERVENTIONAL

Enrollment

27

Start Date

2021-09-09

Completion Date

2024-12-17

Last Updated

2026-06-02

Healthy Volunteers

No

Interventions

DRUG

Maralixibat

Maralixibat chloride provided in the form of an oral solution (i.e., 5, 10, 15, and 20 mg/mL) * 400 μg/kg maralixibat chloride is equivalent to 380 µg/kg maralixibat free base * 600 μg/kg maralixibat chloride is equivalent to 570 µg/kg maralixibat free base

Locations (14)

Children Hospital LA

Los Angeles, California, United States

University of California - San Francisco

San Francisco, California, United States

Medstar Georgetown University Hospital

Washington D.C., District of Columbia, United States

Ochsner Hospital for Children

New Orleans, Louisiana, United States

Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, United States

Texas Children's Hospital

Houston, Texas, United States

Seattle Children's Hospital

Seattle, Washington, United States

Cliniques Universitaires Saint-Luc

Brussels, Belgium

Sociedade Beneficente de Senhoras - Hospital Sírio-Libanês

São Paulo, Brazil

Hôpital Kremlin Bicêtre

Le Kremlin-Bicêtre, France

Hopital Necker

Paris, France

Consultorio de Joshue David Covarrubias Esquer

Zapopan, Mexico

Instytut Pomnik-Centrum Zdrowia Dziecka

Warsaw, Poland

King's College Hospital

London, United Kingdom